India office of US Cranberry Marketing Committee recently conducted a series of insightful and interactive sessions with leading gut specialists, gastroenterologists and endocrinologists across seven Indian cities, to create awareness and share critical insights on the benefits of Cranberry juice in prevention of H Pylori bacterial infection and strengthen gut health.
The sessions were addressed by Dr Jignesh Gandhi (Senior Consultant at the Department of General & Laparoscopic Surgery, Fortis Hospitals, Mumbai), Dr Amy B Howell, (PhD Associate Research Scientist Marucci Center for Blueberry Cranberry Research Rutgers University, USA) who joined the session virtually and Sumit Saran, US Cranberry Marketing Committee - India Representative.
Dr Jignesh Gandhi said, “H Pylori bacterial infection is menacing threat to India's health and it's healthy economy. About 60 per cent of our Indian population is affected by the H Pylori bacteria of which around 3 per cent can have active ulcer disease with few of them leading to surgical complications and small percentage having a life time risk to develop stomach cancer. We have around 50,000 patients seeking treatment for H pylori across in form of triple drug medical therapy for a duration of 2 weeks as a standard of care.”
Dr Howell mentioned that consumption of 100 per cent cranberry juice regularly is a complementary approach towards the suppression of H Pylori infection and it should not be looked upon as a replacement or substitute for antibiotics.
Elaborating on the India market, Sumit Saran, India Representative of US Cranberries said, “US cranberries in India are commonly available in dried or in juice form. It can be easily bought from major e-commerce platforms or leading retailers across the country.”